Payment and billing strategies to support methadone take-home medication: Perspectives of financial leaders of opioid treatment program organizations in New York State.
J Subst Use Addict Treat.
2025 Jan;168:209547. doi: 10.1016/j.josat.2024.209547. Epub 2024 Oct 20. PubMed PMID:
39437902.
Patient experiences in outpatient substance use disorder treatment: A qualitative study exploring both clinical and non-clinical contexts.
J Subst Use Addict Treat.
2024 Nov 16;169:209581. doi: 10.1016/j.josat.2024.209581. [Epub ahead of print] PubMed PMID:
39557341.
Leveraging Implementation Factors and Policy to Improve the Effectiveness of Naloxone.
J Addict Med.
2024 Nov 8;. doi: 10.1097/ADM.0000000000001406. [Epub ahead of print] PubMed PMID:
39514894.
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States.
Addiction.
2024 Oct 25;. doi: 10.1111/add.16691. [Epub ahead of print] PubMed PMID:
39450522.
Drug Overdose Death Following Substance Use Disorder Treatment Termination in New York City: A Retrospective Longitudinal Cohort Study.
J Urban Health.
2024 Oct;101(5):1045-1057. doi: 10.1007/s11524-024-00893-5. Epub 2024 Aug 2. PubMed PMID:
39095494; PubMed Central PMCID:
PMC11461374.
Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults.
PLoS One.
2024;19(8):e0297567. doi: 10.1371/journal.pone.0297567. eCollection 2024. PubMed PMID:
39141672; PubMed Central PMCID:
PMC11324150.
The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination.
Clin Infect Dis.
2024 May 15;78(5):1235-1239. doi: 10.1093/cid/ciad503. Review. PubMed PMID:
37633653; PubMed Central PMCID:
PMC11093654.
Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations.
Drug Alcohol Depend.
2024 May 1;258:111283. doi: 10.1016/j.drugalcdep.2024.111283. Epub 2024 Apr 3. PubMed PMID:
38581920; PubMed Central PMCID:
PMC11088491.
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City.
Harm Reduct J.
2023 Oct 18;20(1):152. doi: 10.1186/s12954-023-00891-x. PubMed PMID:
37853481; PubMed Central PMCID:
PMC10585909.
Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City.
Res Sq.
2023 May 17;. doi: 10.21203/rs.3.rs-2934002/v1. PubMed PMID:
37292718; PubMed Central PMCID:
PMC10246282.
Commentary on Iversen et al.: Adapting public health surveillance and monitoring to reflect how DAAs are changing the epidemiology of hepatitis C virus infection.
Addiction.
2023 May;118(5):912-913. doi: 10.1111/add.16139. Epub 2023 Feb 6. PubMed PMID:
36744496.
Understanding Vaccine Perceptions and Willingness to Receive COVID-19 Vaccination: Opportunities to Strengthen Public Health Responses and COVID-19 Services for People Who Use Drugs.
Vaccines (Basel).
2022 Nov 29;10(12). doi: 10.3390/vaccines10122044. PubMed PMID:
36560454; PubMed Central PMCID:
PMC9784169.
Changes in General Health and Mental Health Outcomes in an Urban Population Over a Decade: A Population-Representative Analysis Stratified by Sexual Orientation.
LGBT Health.
2022 Oct;9(7):512-519. doi: 10.1089/lgbt.2021.0217. Epub 2022 Jul 25. PubMed PMID:
35877080; PubMed Central PMCID:
PMC11391887.
Toward a Theory of the Underpinnings and Vulnerabilities of Structural Racism: Looking Upstream from Disease Inequities among People Who Use Drugs.
Int J Environ Res Public Health.
2022 Jun 17;19(12). doi: 10.3390/ijerph19127453. Review. PubMed PMID:
35742699; PubMed Central PMCID:
PMC9224240.
Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A "Big Events" Perspective.
Int J Environ Res Public Health.
2022 Jan 17;19(2). doi: 10.3390/ijerph19020995. PubMed PMID:
35055817; PubMed Central PMCID:
PMC8776232.
Better Screening Value of Sylvian Fissure Ratio on Cognitive Decline Among Female Compared to Male: An Observational Study in Elderly Patients With Cerebral Small Vessel Disease in Soochow.
Front Neurosci.
2021;15:729782. doi: 10.3389/fnins.2021.729782. eCollection 2021. PubMed PMID:
34675766; PubMed Central PMCID:
PMC8524438.
Big Events theory and measures may help explain emerging long-term effects of current crises.
Glob Public Health.
2021 Aug-Sep;16(8-9):1167-1186. doi: 10.1080/17441692.2021.1903528. Epub 2021 Apr 11. PubMed PMID:
33843462; PubMed Central PMCID:
PMC8338763.
Technology-Based Interventions to Increase Point-of-Care HIV Testing and Linkage to Care Among Youth in the US: A Systematic Review.
AIDS Behav.
2021 Jun;25(6):1829-1838. doi: 10.1007/s10461-020-03112-9. Epub 2020 Nov 24. Review. PubMed PMID:
33231846; PubMed Central PMCID:
PMC7684145.
Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City.
Subst Use Misuse.
2021;56(5):728-737. doi: 10.1080/10826084.2021.1892142. Epub 2021 Mar 7. PubMed PMID:
33682610; PubMed Central PMCID:
PMC8514132.
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
J Infect Dis.
2020 Sep 2;222(Suppl 5):S322-S334. doi: 10.1093/infdis/jiz659. PubMed PMID:
32877567; PubMed Central PMCID:
PMC7566606.
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
J Infect Dis.
2020 Sep 2;222(Suppl 5):S335-S345. doi: 10.1093/infdis/jiz686. PubMed PMID:
32877560; PubMed Central PMCID:
PMC7566623.
Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.
Clin Infect Dis.
2020 Jun 10;70(12):2652-2662. doi: 10.1093/cid/ciz726. PubMed PMID:
31400755; PubMed Central PMCID:
PMC7286369.
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.
J Clin Virol.
2020 Mar;124:104285. doi: 10.1016/j.jcv.2020.104285. Epub 2020 Jan 27. PubMed PMID:
32007842; PubMed Central PMCID:
PMC7195813.
Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
PLoS One.
2018;13(11):e0206356. doi: 10.1371/journal.pone.0206356. eCollection 2018. PubMed PMID:
30496209; PubMed Central PMCID:
PMC6264850.
The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.
Curr HIV/AIDS Rep.
2018 Apr;15(2):96-112. doi: 10.1007/s11904-018-0390-3. Review. PubMed PMID:
29460225; PubMed Central PMCID:
PMC5884743.
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Addiction.
2018 Mar;113(3):545-563. doi: 10.1111/add.14012. Epub 2017 Oct 23. PubMed PMID:
28891267; PubMed Central PMCID:
PMC5836947.
Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.
J Clin Epidemiol.
2018 Jan;93:66-75. doi: 10.1016/j.jclinepi.2017.10.015. Epub 2017 Nov 2. PubMed PMID:
29102682; PubMed Central PMCID:
PMC5767157.
Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
J Public Health Manag Pract.
2018 Jan/Feb;24(1):41-48. doi: 10.1097/PHH.0000000000000519. PubMed PMID:
28141668.
Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.
Front Public Health.
2017;5:348. doi: 10.3389/fpubh.2017.00348. eCollection 2017. PubMed PMID:
29326922; PubMed Central PMCID:
PMC5741609.
Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.
JMIR Res Protoc.
2017 Oct 20;6(10):e201. doi: 10.2196/resprot.7936. PubMed PMID:
29054830; PubMed Central PMCID:
PMC5670319.
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization.
J Ethn Subst Abuse.
2017 Oct-Dec;16(4):404-419. doi: 10.1080/15332640.2017.1292418. Epub 2017 Mar 17. PubMed PMID:
28306386; PubMed Central PMCID:
PMC6155481.
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Cochrane Database Syst Rev.
2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Review. PubMed PMID:
28922449; PubMed Central PMCID:
PMC5621373.
Considerations for the Development of a Substance-Related Care and Prevention Continuum Model.
Front Public Health.
2017;5:180. doi: 10.3389/fpubh.2017.00180. eCollection 2017. PubMed PMID:
28770195; PubMed Central PMCID:
PMC5513894.
Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.
J Subst Abuse Treat.
2017 Jun;77:31-37. doi: 10.1016/j.jsat.2017.03.007. Epub 2017 Mar 12. Review. PubMed PMID:
28476268; PubMed Central PMCID:
PMC5699231.
The Shift in Emphasis From Risk-Based to Age-Based Hepatitis C Virus (HCV) Testing in the US Tends to Remove Injection Drug Use From Discourse on HCV.
Subst Use Misuse.
2017 Feb 23;52(3):340-350. doi: 10.1080/10826084.2016.1225767. Epub 2016 Oct 21. PubMed PMID:
27768548.
Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis.
Int J STD AIDS.
2017 Feb;28(2):145-159. doi: 10.1177/0956462416630910. Epub 2016 Jul 10. Review. PubMed PMID:
26826159; PubMed Central PMCID:
PMC4965334.
Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.
Front Public Health.
2016;4:296. doi: 10.3389/fpubh.2016.00296. eCollection 2016. Review. PubMed PMID:
28119910; PubMed Central PMCID:
PMC5222805.
To neither target, capture, surveille, nor wage war: On-going need for attention to metaphor theory in care and prevention for people who use drugs.
J Addict Dis.
2017 Jan-Mar;36(1):1-4. doi: 10.1080/10550887.2016.1258169. Epub 2016 Nov 9. PubMed PMID:
27827568.
Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.
BMC Infect Dis.
2016 Sep 5;16(1):471. doi: 10.1186/s12879-016-1807-5. Review. PubMed PMID:
27595855; PubMed Central PMCID:
PMC5011802.
The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis.
Syst Rev.
2016 Jul 11;5(1):110. doi: 10.1186/s13643-016-0293-6. PubMed PMID:
27401499; PubMed Central PMCID:
PMC4940695.
Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply.
AIDS.
2016 Jun 19;30(10):1685. doi: 10.1097/QAD.0000000000001091. PubMed PMID:
27243778.
Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs.
Cochrane Database Syst Rev.
2016;2016(1). doi: 10.1002/14651858.CD012021. Epub 2016 Jan 12. PubMed PMID:
27127417; PubMed Central PMCID:
PMC4843520.
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.
Int J Drug Policy.
2015 Nov;26(11):1056-63. doi: 10.1016/j.drugpo.2015.04.015. Epub 2015 Apr 27. PubMed PMID:
26050614; PubMed Central PMCID:
PMC4581906.
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.
AIDS.
2015 Nov;29(17):2335-45. doi: 10.1097/QAD.0000000000000834. Review. PubMed PMID:
26258525; PubMed Central PMCID:
PMC4640945.
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.
Int J Drug Policy.
2015 Oct;26(10):911-21. doi: 10.1016/j.drugpo.2015.07.004. Epub 2015 Jul 26. Review. PubMed PMID:
26298331; PubMed Central PMCID:
PMC4577462.
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
Drug Alcohol Depend.
2015 Jul 1;152:194-200. doi: 10.1016/j.drugalcdep.2015.03.039. Epub 2015 Apr 13. PubMed PMID:
25891230; PubMed Central PMCID:
PMC4458155.
Hepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.
JMIR Res Protoc.
2015 Jun 8;4(2):e68. doi: 10.2196/resprot.4518. PubMed PMID:
26054636; PubMed Central PMCID:
PMC4526911.
Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance.
Drug Alcohol Depend.
2015 Apr 1;149:285-9. doi: 10.1016/j.drugalcdep.2015.02.007. Epub 2015 Feb 17. PubMed PMID:
25735466; PubMed Central PMCID:
PMC4391061.
Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.
Int J Drug Policy.
2015 Feb;26(2):217-9. doi: 10.1016/j.drugpo.2014.10.006. Epub 2014 Oct 31. PubMed PMID:
25465345; PubMed Central PMCID:
PMC4445640.
Perceptions of genetic testing and genomic medicine among drug users.
Int J Drug Policy.
2015 Jan;26(1):100-6. doi: 10.1016/j.drugpo.2014.06.013. Epub 2014 Jun 24. PubMed PMID:
25037119; PubMed Central PMCID:
PMC4276555.
What would you like to do?